V P Castle

Author PubWeight™ 21.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis. Anticancer Res 2000 1.46
2 Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway. J Vasc Res 2000 1.42
3 NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J Biol Chem 2001 1.39
4 Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 1994 1.32
5 Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res 1995 1.30
6 Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am J Pathol 1997 1.23
7 Successful treatment of infantile hemangiomas with interferon-alpha-2b. J Pediatr Hematol Oncol 1997 1.16
8 Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation. J Pediatr 1997 1.10
9 Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. Radiology 1996 1.08
10 IGF-I receptor activation and BCL-2 overexpression prevent early apoptotic events in human neuroblastoma. Cell Death Differ 2000 0.97
11 Insulin-like growth factor II in the pathogenesis of human neuroblastoma. Am J Pathol 1995 0.94
12 Bcl-xS enhances adenoviral vector-induced apoptosis in neuroblastoma cells. Cancer Res 1996 0.88
13 Bcl-2 and M-Myc coexpression increases IGF-IR and features of malignant growth in neuroblastoma cell lines. Neoplasia 2001 0.87
14 Successful bone marrow transplantation in a patient with Schimke immuno-osseous dysplasia. J Pediatr 2000 0.85
15 Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies. Radiology 1995 0.84
16 Role of p53 in the regulation of irradiation-induced apoptosis in neuroblastoma cells. Mol Genet Metab 1998 0.82
17 Successful treatment of neonatal arterial thromboses with recombinant tissue plasminogen activator. J Pediatr 1998 0.82
18 Neonatal purpura fulminans in association with factor V R506Q mutation. J Pediatr 1996 0.82
19 Kasabach-Merritt syndrome: treatment with epsilon-aminocaproic acid and assessment by indium 111 platelet scintigraphy. J Pediatr 1990 0.81
20 Fatal lymphoproliferative disease as a complication of Evans syndrome. J Pediatr Hematol Oncol 2000 0.80
21 Congenital mesoblastic nephroma metastatic to the brain: a report of two cases. Pediatr Radiol 1995 0.78
22 PET hydroxyephedrine imaging of neuroblastoma. J Nucl Med 1996 0.77
23 The response to splenectomy in pediatric patients with idiopathic thrombocytopenic purpura who fail high-dose intravenous immune globulin. J Pediatr Surg 2000 0.76
24 Lineage switch in Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer 1994 0.75